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Abstract
Background: Anxiety and depression are two important contributors to the global burden of disease. In many
developing countries, including Nepal, their prevalences are yet to be assessed.
Methods: A nationwide cross-sectional study was conducted among a representative sample of Nepalese adults
aged 18–65 years (N = 2100), selected by multistage random cluster sampling and interviewed at home during
unannounced visits. The validated questionnaires included the Hospital Anxiety and Depression Scale (HADS), to
detect cases of anxiety (HADS-A), depression (HADS-D) and comorbid anxiety and depression (HADS-cAD), the
Eysenck Personality Questionnaire Revised Short Form-Neuroticism (EPQRS-N), and the World Health Organization
Quality of Life 8-question scale (WHOQOL-8). Logistic regression analyses were used to explore associations of
caseness with four groups of variables: demographic, domicile, substance use, and behavioural and health.
Results: Age- and gender-adjusted point prevalences of HADS-A, HADS-D and HADS-cAD were 16.1, 4.2 and 5.9 %
respectively. In a multivariate model, HADS-A was positively associated with urban residence (AOR = 1.82; p < 0.001)
and neuroticism (AOR = 1.32; p < 0.001), and negatively with alcohol consumption (AOR = 0.71; p = 0.041). HADS-D
was positively associated with marijuana use (AOR = 3.61; p = 0.017) and negatively with quality of life (QoL)
(AOR = 0.86; p < 0.001). HADS-cAD was positively associated with widowhood (AOR = 2.71; p = 0.002), urban
residence (AOR = 2.37; p = 0.001), living at altitude ≥2000 m (AOR = 2.32; p = 0.002) and neuroticism (AOR = 1.26;
p < 0.001), and negatively with alcohol use (AOR = 0.56; p = 0.026) and QoL (AOR = 0.79; p < 0.001).
Conclusion: Depression and anxiety are important mental health conditions in Nepal, and major contributors to
public ill health, being very highly prevalent, comorbid and associated with psychosocial burden. They are also
linked to the unique topography, habitation and social structure of the country. High prevalence coupled with the
disabling nature of these disorders establishes their health-care priority and their importance in national health
policy.
Keywords: Anxiety, Depression, Developing countries, Health policy, Mental health, Neuroticism, Public health,
South Asia, Urbanization, Widowhood
Background
Anxiety and depression embrace a range of mental con-
ditions occurring frequently in primary health care, usu-
ally in the form of overt disorders. They are
acknowledged as common mental disorders (CMDs) [1, 2]
and, in terms of their ubiquity and the burdens they im-
pose, as major disorders of the brain [3]. In the recent
Global Burden of Disease Study 2013 (GBD 2013), while
mental and substance use disorders collectively accounted
for 21.2 % of all years of life lost to disability (YLDs) [4],
depression and anxiety were ranked second and ninth
highest specific causes of YLDs in both developed and de-
veloping countries. These disorders are therefore of
considerable public-health importance [5] in high-
income [6, 7] and low- and middle-income (LAMI)
countries [8] alike. They are also highly comorbid [9].
Extrapolations from GBD 2013 data indicate that de-
pression and anxiety are among the top ten causes of
YLDs in South Asia, which includes Nepal [4]; however,
no research has been undertaken to make direct national
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estimates in this Region. Available studies were limited to
a few scattered health centres [10, 11], districts [12–14],
villages [15] or cities [16], and could not comprehensively
describe the prevalence of CMDs, let alone provide an ac-
count of the burdens attributable to them.
With these factors under consideration, our principal
aim was to assess health-care needs by estimating the
prevalences of anxiety and depression in Nepal, using a
well-validated and culturally-adapted screening instru-
ment [17]. Also, we wished to establish their degree of
comorbidity, as well as their associations with sociode-
mographic characteristics, social behaviours and health-
related factors. This would fill current knowledge gaps
regarding these CMDs in the South Asian Region, and
serve our overall purpose of guiding public-health policy
towards better mental health in Nepal.
There were methodological issues to be considered.
Most earlier South Asian studies utilized self-report
scales with caseness of anxiety [10, 12] or depression
[13–15] being indicated by summed scores at or above
defined thresholds. Such scales are useful in areas with
inadequate or unevenly distributed resources that greatly
limit epidemiological surveys [18]. This was certainly
true of Nepal, one of the poorest nations of the world
[19]. Furthermore, its geographical and sociocultural di-
versities posed unique logistic and methodological diffi-
culties which our survey had to overcome [20, 21]. We
considered important the relationships between mental
wellbeing and behaviours typical of life and culture in
the Nepalese community [20], such as the use of alcohol
and marijuana during festivals, and the common method
of carrying heavy loads on the back, suspended by a
tumpline around the forehead. We also considered per-
sonality traits associated with psychopathology (neuroti-
cism), and measures of burden in the face of hardship
(“life toughness”), including impairment of quality of life
(QoL), since these might be pertinent. In selecting covar-
iates for analysis of associations, we had no previous re-
search to draw upon. However, the data were gathered
in the context of a nationwide survey of headache disor-
ders [22, 23], which incorporated a range of demo-
graphic, environmental and health variables.
Methods
Ethics
This study was part of a larger research project address-
ing the major disorders of the brain in Nepal [20], ap-
proved by the Nepal Health Research Council (NHRC),
the Institutional Review Committee of Kathmandu Uni-
versity School of Medical Sciences, Dhulikhel Hospital,
and the Regional Committee for Health and Research
Ethics in Central Norway. Informed consent was given
by all participants and confirmed either by signature or
by fingerprint.
Study design and sampling
This was a cross-sectional study in which unannounced
household visits were made during May 2013 by trained
interviewers using structured questionnaires. To obtain
a representative sample of the adult general population,
we used a multistage random cluster-sampling technique
to select households in all three physiographic divisions
of the country and, within each division, all five develop-
ment regions (Far-Western, Mid-Western, Western,
Central and Eastern). From each household we ran-
domly selected one adult aged 18–65 years. This proced-
ure has been explained in more detail elsewhere [21].
Study instruments
Hospital Anxiety and Depression Scale (HADS)
We used a validated Nepali translation of HADS [17] to
estimate the prevalence of anxiety and depression.
HADS consists of 14 items in two subscales: HADS-
Anxiety and HADS-Depression, each of seven items. In
relation to each item, participants report their sub-
jective experience during the preceding week, which
is rated 0–3 (3 indicating maximum symptom sever-
ity). The sum of each subscale has a potential range
of 0–21. As recommended in the original English ver-
sion [24], and validated in the Nepali translation [21],
we used a threshold of 11 on the respective subscale
to indicate caseness for anxiety or depression.
Eysenck personality questionnaire revised short form-
neuroticism (EPQRS-N)
We used a validated Nepali translation of EPQRS-N [25]
to assess the degree of neuroticism [26] in the survey
participants. EPQRS-N has 12 items, each a question with
response options “No” (scored 0) and “Yes” (scored 1).
The sum of responses has a potential range of 0–12,
higher values indicating more neuroticism.
World Health Organization Quality-of-Life 8-question scale
(WHOQOL-8)
The culturally adapted version of WHOQOL-8 [27] was
also used. This instrument consists of eight questions
addressing perceived aspects of a person’s QoL: satisfac-
tion with health and with oneself, the ability to perform
daily activities, personal relations and living conditions,
the sense of subjective adequacy of available resources,
and the sense of having enough energy and means to
meet one’s needs. Each question has five response op-
tions on a Likert scale, and is scored from 1 (worst) to 5
(best); the summed score has the potential range of 8–
40. Higher total scores indicate better QoL.
HARDSHIP questionnaire
All these instruments were incorporated as modules into
the Headache-Attributed Restriction, Disability, Social
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Handicap and Impaired Participation (HARDSHIP)
questionnaire. This instrument was originally designed
to be administered by trained lay interviewers for asses-
sing headache disorders [28], and in our study it was
translated and culturally adapted for Nepal [29]. Separ-
ate sections covered demographic characteristics (age,
gender, marital status and household consumption),
household location (urban or rural, and altitude), use of
substances (alcohol, tobacco and marijuana), tumpline
use (frequency and heaviness of load), height and weight
(from which body mass index [BMI] was computed) and
blood pressure (BP). Finally, we included a question on
life-toughness, with five ordinal response options from
“very easy” to “very tough”.
Statistical analysis
Analyses were carried out using IBM SPSS Statistics 21.
We used caseness as defined by HADS to compute the
crude prevalences of anxiety and depression. Participants
scoring above the thresholds of both subscales were con-
sidered as cases of comorbid anxiety and depression
(cAD). In order to examine associations, we separated
HADS-cAD cases from participants scoring above the
thresholds only for anxiety (HADS-A cases) or only for
depression (HADS-D cases). Since HADS takes account
only of very recent subjective experience (in the past
week) [24], prevalence estimates approximate to point
prevalences. Thus we calculated the point prevalences of
anxiety, depression, HADS-A, HADS-D and HADS-
cAD, reporting the estimates as percentages with 95 %
confidence intervals (CIs). Our sample was under-
represented by young males aged 18–34 years in com-
parison to the recent national population census of
Nepal [21]. Hence, we adjusted our observed estimates
by standardization according to the age and gender dis-
tributions of the national population [30].
We used bivariate logistic regression to identify associ-
ations with the categorical variables: demographic char-
acteristics including age (categorized 18–25, 26–35, 36–
45, 46–55, 56–65 years), habitation (urban or rural), alti-
tude of domicile (<2000 or ≥2000 m), use of substances
(yes/no for each of alcohol, tobacco and marijuana), fac-
tors related to tumpline use (frequency: never, some-
times or daily; heaviness of load [assessed subjectively]:
light, moderate or heavy), life-toughness (assessed sub-
jectively: easy, medium or tough), BP and BMI. We cate-
gorized BP as hypertensive or non-hypertensive
according to the Joint National Committee on Preven-
tion, Detection, Evaluation, and Treatment of High
Blood Pressure criteria (JNC7) [31]. BMI was catego-
rized as underweight (<18.5), normal (18.5–24.99) or
overweight (≥25) [32]. We used Pearson correlation to
test associations between HADS-Anxiety and HADS-
Depression total scores and continuous variables:
neuroticism and WHOQOL-8 scores. In view of the
high number of participants relative to the number of
variables in the analyses, we set the level of significance
at p < 0.05.
Variables that showed no significant associations in bi-
variate analyses were excluded from multivariate ana-
lyses. The remaining variables were divided into four
blocks and entered into logistic regression analyses:
demographic (age and gender) in block A, domicile
(habitation and altitude) in block B, substance use in
block C and behavioural and health variables (tumpline
use, life toughness, neuroticism and WHOQOL-8) in
block D. Adjusted odds ratios (AORs) with 95 % CI for
each independent variable were calculated. Age was used
as a continuous variable in the multivariate computations.
Prevalences of the three derived types of caseness, HADS-
A, HADS-D and HADS-cAD, were the dependent
variables.
Results
The total sample included 2100 participants (males: 861
[41.0 %], females: 1239 [59.0 %], mean age 36.4 ±
12.8 years). The participation rate was 99.6 %. There
were no missing data.
Prevalence
The crude prevalence of anxiety was 22.7 % and of de-
pression 11.7 %. The age- and gender-adjusted preva-
lence of HADS-A was 16.1 %, of HADS-D 4.2 % and of
HADS-cAD 5.9 % (Table 1).
Associations
Anxiety caseness and depression caseness were very
strongly associated (OR = 5.6 [95 % CI: 4.2–7.4]; p <
0.001). We arrived at this result either by taking HADS-
A +HADS-cAD (all anxiety) as the independent variable
and HADS-D +HADS-cAD (all depression) as the
dependent, or by the reverse analysis (depression inde-
pendent, anxiety dependent).
In the bivariate analysis (Table 2), HADS-A was sig-
nificantly more prevalent among females (OR = 1.4). It
Table 1 Point prevalences (%) of each disorder according to
caseness as defined (see text) (N = 2100)
Caseness Point prevalence
n % 95 % CI Age- and gender-adjusted a (%)
Anxiety 477 22.7 20.9–24.5 -
Depression 246 11.7 10.3–13.1 -
HADS-A 340 16.2 14.6–17.8 16.1
HADS-D 109 5.2 4.2–6.1 4.2
HADS-cAD 137 6.5 5.4–7.5 5.9
a Adjusted for age and gender according to the Nepal Population Report,
2011 [30]
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Table 2 Bivariate analyses of associations of caseness by HADS-A, HADS-D and HADS-cAD with categorical demographic, environ-
mental and behavioural factors
Variable N HADS-A (n = 340) HADS-D (n = 109) HADS-cAD (n = 137)
Prevalence OR p Prevalence OR p Prevalence OR p
n (%) 95 % CI n (%) 95 % CI n (%) 95 % CI
Age (years)
18–25 489 84 (17.2) Reference - 12 (2.5) Reference - 20 (4.1) Reference -
26–35 657 115 (17.5) 1.0 [0.8–1.4] 0.89 23 (3.5) 1.4 [0.7–2.9] 0.31 30 (4.6) 1.1 [0.6–2.0] 0.69
36–45 438 65 (14.8) 0.8 [0.6–1.2] 0.33 25 (5.7) 2.4 [1.2–4.9] 0.014 31 (7.1) 1.8 [1.0–3.2] 0.049
46–55 298 49 (16.4) 0.95 [0.6–1.4] 0.79 26 (8.7) 3.8 [1.9–7.7] <0.001 28 (9.4) 2.4 [1.3–4.4] 0.003
56–65 218 27 (12.4) 0.7 [0.4–1.1] 0.11 23 (10.6) 4.7 [2.3–9.6] <0.001 28 (12.8) 3.5 [1.9–6.3] <0.001
Gender
male 861 119 (13.8) Reference - 42 (4.9) Reference - 44 (5.5) Reference -
female 1239 221 (17.8) 1.4 [1.1–1.7] 0.014 67 (5.4) 1.1 [0.8–1.7] 0.59 93 (7.5) 1.5 [1.0–2.2] 0.031
Marital status
married 1738 285 (16.4) Reference - 92 (5.3) Reference - 104 (6.0) Reference -
single 239 35 (14.6) 0.9 [0.6–1.3] 0.49 5 (2.1) 0.4 [0.2–0.95] 0.038 8 (3.3) 0.5 [0.3–1.1] 0.10
separated or divorced 20 4 (20) 1.3 [0.4–3.8] 0.66 2 (10) 2.0 [0.5–8.7] 0.36 1 (5.0) 0.8 [0.1–6.2] 0.85
widowed 103 16 (15.5) 0.9 [0.5–1.6] 0.82 10 (9.7) 1.9 [1.0–3.8] 0.061 24 (23.3) 4.8 [2.9–7.9] <0.001
Household consumption (USD/year)
≤950 822 128 (15.6) 1.0 [0.8–1.3] 0.97 54 (6.6) 1.5 [1.0–2.3] 0.065 54 (6.6) 1.1 [0.7–1.6] 0.68
950–1200 806 126 (15.6) Reference - 36 (4.5) Reference - 49 (6.1) Reference -
>1200 472 86 (18.2) 1.2 [0.9–1.6] 0.23 19 (4) 0.9 [0.5–1.6] 0.71 34 (7.2) 1.2 [0.8–1.9] 0.43
Habitation
rural 1328 206 (15.5) Reference - 76 (5.7) Reference - 84 (6.3) Reference -
urban 772 134 (17.4) 1.1 [0.9–1.5] 0.27 33 (4.3) 0.7 [0.5–1.1] 0.15 53 (6.9) 1.1 [0.8–1.6] 0.63
Dwelling altitude
<2000 m 1630 253 (15.5) Reference - 71 (4.4) Reference - 89 (5.5) Reference -
≥2000 m 470 87 (18.5) 1.2 [0.9–1.6] 0.12 38 (8.1) 1.9 [1.3–2.9] 0.002 48 (10.2) 2.0 [1.4–2.8] <0.001
Tobacco smoking
no 1613 265 (16.4) Reference - 76 (4.7) Reference - 91 (5.6) Reference -
yes 487 75 (15.4) 0.6 [0.7–1.2] 0.20 33 (6.8) 1.5 [1.0–2.2] 0.073 46 (9.4) 1.7 [1.2–2.5] 0.003
Alcohol consumption
no 1512 260 (17.2) Reference - 77 (5.1) Reference - 106 (7.0) Reference -
yes 588 80 (13.6) 0.8 [0.6–0.99] 0.045 32 (5.4) 1.1 [0.7–1.6] 0.75 31 (5.6) 0.7 [0.5–1.1] 0.15
Marijuana use
no 2065 335 (16.2) Reference - 104 (5) Reference - 134 (6.5) Reference -
yes 35 5 (14.3) 0.9 [0.3–2.2] 0.76 5 (14.3) 3.1 [1.2–8.3] 0.020 8 (3.6) 1.4 [0.4–4.5] 0.62
Tumpline use: frequency
never 801 125 (15.6) Reference - 29 (3.6) Reference - 46 (5.7) Reference -
sometimes 532 89 (16.7) 1.1 [0.8–1.5] 0.58 28 (5.3) 1.5 [0.9–2.5] 0.15 24 (4.5) 0.8 [0.5–1.2] 0.32
daily 767 126 (16.4) 1.1 [0.8–1.4] 0.66 52 (6.8) 1.9 [1.2–3.1] 0.005 67 (8.7) 1.6 [1.1–2.3] 0.023
Tumpline use: heaviness of load
never used 801 125 (15.6) Reference - 29 (3.6) Reference - 46 (5.7) Reference -
light, moderate 801 116 (14.5) 0.9 [0.7–1.2] 0.53 45 (5.6) 1.6 [1.0–2.6] 0.06 44 (5.5) 1.0 [0.6–1.5] 0.83
heavy 498 99 (19.9) 1.3 [1.0–1.8] 0.048 35 (7.0) 2.0 [1.2–3.3] 0.007 47 (9.4) 1.7 [1.1–2.6] 0.013
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was negatively associated with alcohol use (OR = 0.8),
but more prevalent among those reporting the carrying
of heavy tumpline loads (OR = 1.3) and among those
who felt that life was tough (OR = 2.6). HADS-Anxiety
total scores correlated positively with neuroticism (r = 0.57;
p < 0.001) and negatively with WHOQOL-8 (r = -0.45; p <
0.001).
In the multivariate analysis, the association with fe-
male gender did not survive, but the negative association
with alcohol use did (AOR = 0.7 [95 % CI: 0.5–0.98]; p =
0.041). Additionally, a strong association emerged with
urban habitation (AOR = 1.8 [95 % CI: 1.3–2.5]; p <
0.001). A modest negative association with daily tump-
line use (AOR = 0.7 [95 % CI: 0.4–0.97]; p = 0.033) re-
placed the positive association with heavy tumpline
loads. The prevalence of HADS-A was higher among high
scorers on neuroticism (AOR= 1.3 [95 % CI: 1.3–1.4]; p <
0.001) but the negative association with WHOQOL-8, al-
though significant, was very weak (AOR = 0.95 [95 % CI:
0.9–0.99]; p = 0.009).
HADS-D in the bivariate analysis (Table 2) showed a
strongly ascending trend with age, the association being
significant after age 35. HADS-D in this analysis was
more prevalent among the high-altitude dwellers (OR =
1.9), marijuana users (OR = 3.1), daily tumpline users
(OR = 1.9), those reporting carriage of heavy tumpline
loads (OR = 2.0) and those reporting that their lives were
tough (OR = 2.3). An association with low household
consumption (OR = 1.5), a proxy for relative poverty,
was not quite significant. HADS-Depression total
scores correlated positively with neuroticism (r = 0.32;
p < 0.001) and negatively with WHOQOL-8 (r = -0.50;
p < 0.001).
Only the positive association with marijuana use
(AOR = 3.6 [95 % CI: 1.2–10.5]; p = 0.018) and the
negative association with WHOQOL-8 (AOR = 0.9
[95 % CI: 0.8–0.9]; p < 0.001) survived the multivariate
analysis.
HADS-cAD showed a similar ascending trend with
age, significant after the age of 35 years (Table 2). In the
bivariate analysis, HADS-cAD was more prevalent
among females (OR = 1.5), the widowed (OR = 4.8),
high-altitude dwellers (OR = 2.0), tobacco users (OR =
1.7), daily tumpline users (OR = 1.6), those carrying
heavy tumpline loads (OR = 1.7) and those reporting that
life was tough (OR = 6.1) (Table 2).
In the multivariate analysis, the associations with
widowhood (AOR = 2.7 [95 % CI: 1.5–5.1]; p = 0.002)
and high altitude dwelling (AOR = 2.3 [95 % CI: 1.4–
3.9]; p = 0.002) survived. Additionally, a positive associ-
ation with urban dwelling (AOR = 2.4 [95 % CI: 1.4–3.9];
p = 0.001) and a negative association with alcohol use
(AOR = 0.6 [95 % CI: 0.3–0.9]; p = 0.026) emerged.
Multivariate analysis also uncovered a positive associ-
ation of HADS-cAD with neuroticism (AOR = 1.3
[95 % CI: 1.2–1.4]; p < 0.001) and a negative associ-
ation with WHOQOL-8 (AOR = 0.8 [95 % CI: 0.75–0.84];
p < 0.001).
There were no associations with BP or BMI.
Discussion
HADS-A was more prevalent among the Nepalese than
HADS-D, while the two conditions were highly comor-
bid with each other. HADS-cAD showed significant as-
sociations with widowhood, urban and high-altitude
dwelling and neuroticism. HADS-A, like HADS-cAD,
was more prevalent among urban dwellers. All three
types of caseness were associated with poorer QoL.
However, comorbid cases containing all elements of
both anxiety and depression were associated, more than
cases of HADS-A or HADS-D only, with life complica-
tions such as those of urban or high-altitude dwelling,
and widowhood. We say more about these later.
Owing to the high comorbidity between anxiety and
depression, psychiatric research tends to report their
combined prevalence: one recent review found the col-
lective worldwide 1-year prevalence of these disorders to
be almost 20 % [5]. However, other recent global reviews
have revealed prevalences separately of depression in the
range 4.4–5.0 % [33] and anxiety in the range 4.8–
10.9 % [34]. Our finding for HADS-D (5.2 %) was at the
upper limit of the global range, but for depression (ie,
adding those cases included among HADS-cAD), at
11.7 % (95 % CI: 10.3–13.1), it was more than double.
Our finding of 16.2 % for HADS-A was already well
above the global range, and for anxiety (adding those in-
cluded in HADS-cAD), at 22.7 % (95 % CI: 20.9–24.5), it
was again more than double. These findings are in keep-
ing with the WHO Mental Health (WMH) survey [35],
which showed anxiety disorders to be the most prevalent
of all mental disorders, but suggest that, in Nepal, both
depression and anxiety are excessively prevalent.
Table 2 Bivariate analyses of associations of caseness by HADS-A, HADS-D and HADS-cAD with categorical demographic, environ-
mental and behavioural factors (Continued)
Life toughness
easy 417 47 (11.3) Reference - 14 (3.4) Reference - 11 (2.6) Reference -
medium 1137 158 (13.9) 1.3 [0.9–1.8] 0.18 55 (4.8) 1.5 [0.8–2.7] 0.21 49 (4.3) 1.7 [0.9–3.2] 0.13
tough 546 135 (24.7) 2.6 [1.8–3.7] <0.001 40 (7.3) 2.3 [1.2–4.2] 0.010 77 (14.1) 6.1 [3.2–11.6] <0.001
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We have exercised caution here, in using the word
“suggest”. It is the case that most of these reviews, as
well as cross-national epidemiological studies [36], found
both depression and anxiety to be more prevalent in the
Western world than in less developed regions such as
South Asia. While genetic, sociocultural, environmental
and other factors might contribute to real differences,
there are important methodological factors to consider
that influence prevalence estimates. Commonly these re-
late to sampling methods, but of specific concern here
are the instruments used. Most Western studies utilized
diagnostic interviews, while surveys in the less-affluent
world used symptom-based scales to screen for psychi-
atric caseness. Accordingly, HADS, which we used, is a
screening instrument for estimating the point preva-
lences of anxiety and depression, and as such it has limi-
tations. It detects the subjective manifestations of
anxiety and depression [24], while vegetative or somatic
symptoms of distress forming parts of the diagnostic
classifications (DSM [37] or ICD [38]) may not be suffi-
ciently captured. Surveys dependent on HADS and simi-
lar instruments may therefore underestimate actual
prevalences, as has been discussed both in the review on
CMDs [5] and in a WMH survey from China [39].
The Chinese study [39] emphasized the relevance of
sociocultural protective factors (family structure, neigh-
bourhood), which are believed to play a buffering role in
most Asian countries [5], including Nepal, against the
distress associated with anxiety or depression. In a dif-
ferent vein, stigma associated with the widespread belief
that disclosure of mental illness might lead to embar-
rassment and discrimination is more common in under-
developed societies, and may contribute towards
underreporting of mental as opposed to physical symp-
toms; this too was evidenced in a WMH multicentre
study [40]. Because these issues were likely to apply to
our study, our findings of excessively prevalent depres-
sion and anxiety in Nepal appear even more remarkable
since they were unlikely to be overestimates.
From the public-health perspective, the importance of
their very high prevalences lies in the associations of
both depression and anxiety with substantial disability.
There is a wealth of evidence of this, including the data
from GBD 2013 [4]: globally, major depressive disorders
are the 2nd highest cause of YLDs (51.8 million per year),
and dysthymia, which is also expected to be captured by
HADS-Depression, is 16th (another 9.8 million YLDs per
year); anxiety disorders are 9th (24.4 million YLDs per
year). These GBD estimates are based on the global
mean prevalences—well below those we have found in
Nepal. In other words, the disability these disorders give
rise to globally [4], great though it is, may not at popula-
tion level match that in Nepal. Important also are our
findings that all of HADS-A, HADS-D and HADS-cAD
were associated with low QoL and high neuroticism, il-
lustrations of their major effects on functioning at indi-
vidual level.
With regard to associations, damage to family or social
functioning is linked to mental ill health [41]. As evi-
dence of this, we found HADS-cAD to be more preva-
lent among widows. Similarly, a cross-national survey
[36], as well as two Asian studies—one from Iran [16]
and one from China [42]—showed a high prevalence of
CMDs among the widowed. Beyond the stress precipi-
tated by a major family life event, widowhood entails
substantial deviance in the societal role as well as in self-
perception: widows perceive a lack of social support
compared with those who are married [43].
Society is made up of households that are characteris-
tic of the habitation where they stand. We found sub-
stantial associations between mental health and the
location of the home: HADS-A and HADS-cAD were
significantly more prevalent among the urban popula-
tion, as was seen for the anxiety disorders in one of the
global reviews [34]. Similarly, in India [44], multiple
effects of unplanned urbanization including fast popula-
tion growth, environmental degradation and sociocul-
tural conflicts were cited as possible contributors of
escalating mental-health problems, particularly depres-
sion and anxiety, among city populations. These may be
applicable also in Nepal: decade-long political conflicts
resulted in rapid migration of villagers into nearby cities,
thus swiftly expanding the urban population [45]. In
addition, other factors may lead to an increase in the
prevalence of psychiatric disorders in the cities [46]: for
example, the tendency of some mentally ill people to set-
tle in towns rather than in the countryside, possibly to
protect them from social stigma, to be away from the
difficulties of rural life, to obtain proper care from social
welfare institutions or better treatment, in search of jobs,
or just to beg.
Habitation in Nepal also includes high hills and moun-
tains, which cover almost one third of the total land area
of the country [47]. So far, no study has explored psychi-
atric illnesses among the occupants of these territories.
This was the first research in the South Asian Region to
demonstrate the possible effect of geographical elevation
on mental health. It showed HADS-cAD to be more
prevalent above 2000 m. Two studies in Peru [48, 49]
and a US study [50] suggested the role of hypoxia and
mitochondrial dysfunction as the possible link between
altitude and depression. There are also studies on high-
altitude ascenders from China [51] and among porters
and trekkers in Nepal [52] that found anxiety to be one
of the most recorded medical symptoms. But further
work is necessary to elucidate whether biological condi-
tions or psychosocial factors related to life adversity, iso-
lation or the limited access to mental-health facilities in
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these areas are responsible for the mental-health
problems.
Our findings of a negative association between alcohol
use and HADS-A (as well as HADS-cAD), and of a posi-
tive relationship between marijuana use and HADS-D,
need cautious interpretation. It is not so simple to cap-
ture the impact of alcohol use in a country like Nepal
where drinking is considered an integral part of social
functioning in most of the so-called Matwali commu-
nity, which traditionally is prone to drinking [53]. Simi-
larly, marijuana, which is also culturally accepted among
the Nepalese, especially during certain religious func-
tions [54], may not show its true relationship with men-
tal health. We were unable fully to evaluate the potential
relationships between substance dependence and mental
health because the length of the questionnaire restricted
us from adding more questions. Further studies are ne-
cessary in this area.
Contrary to global [5, 33, 34] and local studies
[10, 15, 16], we found no gender associations. Per-
haps the somatic symptoms that generally are re-
ported more frequently by depressed females [55]
were not sufficiently captured by HADS, which was
originally constructed to detect emotional symptoms
among hospital populations, and therefore pays less
attention to bodily symptoms [24].
Although many studies have shown associations be-
tween poverty and CMDs in the LAMI countries [56],
we did not find direct support for these. It may be that
our questions on annual household consumption and
monthly expenditure did not estimate well the socioeco-
nomic status of the household; the responses may have
been vaguely reported by the participants, many of
whom were illiterate [30]. In Nepal, where people gener-
ally are poor [19], it is challenging to find a suitable
measure of socioeconomic status in relation to CMD
caseness. Income is not a reliable indicator, consumption
cannot be assessed using direct monetary measures and
proxy measures such as educational status have limited
usefulness in this country with so much illiteracy; all
these issues have been discussed in an earlier publication
[20]. Nevertheless, our observation of high prevalence of
both anxiety and depression among the Nepalese with
relatively low socioeconomic status may well establish
the link between poverty and mental ill-health. As con-
cluded in a WMH survey, income inequality is a possible
factor promoting chronic illnesses like depression [36],
but more so in high-income countries than in the LAMI
countries.
Our study was built upon tried and tested method-
ology [20], a large sample size, a very high participation
rate achieved through careful sampling methodology
[21], completeness of data and representativeness of the
population’s geographical and cultural diversities. These
were the strengths of this study. The cross-sectional na-
ture of the study obviously could not capture the longi-
tudinal, relapsing and remitting course of depression
and anxiety, or illustrate the temporal direction of asso-
ciations with sociodemographic factors [36]. The limita-
tions in the use of HADS rather than expert clinical
interview have been discussed above. However, these are
considerably offset: we believe culturally validated study
instruments account for socially acceptable outcomes
better than the ethnically insensitive diagnostic classifi-
cations relied upon in various cross-national [35] and
global reviews [33].
Conclusion
Our study has opened a neglected research arena [18].
As a pioneering work in assessing prevalences of the
most common mental disorders nationwide, it also
brings out important implications for advancing the field
of mental health in Nepal. We found that depression
and anxiety were highly, perhaps excessively, prevalent
in the country, while noting that these disorders are glo-
bally the second and ninth highest causes of disability.
Also, we found that disadvantaged groups such as
widows and those tolerating hardships and scarcity in
the high hills were more affected. From the public-
health perspective, these are clear, compelling and ur-
gent messages. Depression and anxiety must be among
the health-care priorities in Nepal; there must be expan-
sion, and wider delivery, of mental health care in the
country. In view of the scarce resources, limited health
budget and lack of specialized psychiatric services, inte-
grating care for a substantial majority of those affected
by these disorders into the fabric of national primary
health-care services would be a reasonable goal.
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